-
14341por Nakai, Masato, Morikawa, Kenichi, Hosoda, Shunichi, Yoshida, Sonoe, Kubo, Akinori, Tokuchi, Yoshimasa, Kitagataya, Takashi, Yamada, Ren, Ohara, Masatsugu, Sho, Takuya, Suda, Goki, Ogawa, Koji, Sakamoto, Naoya“…METHODS: In total, 160 patients with early-stage primary HCC treated with RFA were separately analyzed as hepatitis C virus (HCV)-positive and HCV-negative. Factors contributing to recurrence and liver-related death, including M2BP, M2BPGi, and skeletal muscle mass index, were statistically analyzed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14342por Vignier, Nicolas, Moussaoui, Sohela, Marsaudon, Antoine, Wittwer, Jérome, Jusot, Florence, Dourgnon, Paul“…Apart from dental issues, 12.9% reported suffering from at least one infectious disease: HIV infection (3.5%), chronic hepatitis B virus infection (3.1%), upper respiratory tract infection (1.7%), skin mycosis (1.2%), skin and soft tissue infection (0.8%), chronic hepatitis C infection (0.8%), urinary tract infection (0.7%), lower respiratory tract infection (0.7%), scabies (0.3%), tuberculosis disease (0.2%), vaginal mycosis (0.6%), and herpes (0.1%). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14343“…Demographic and etiological factors and OS were analyzed based on distribution into three groups according to the period and key changes in diagnostic and therapeutic approaches (BCLC classification staging; standardization of protocol for transarterial chemoembolization (TACE) and the introduction of direct-acting antivirals (DAA) for the treatment of chronic viral hepatitis C (HCV); expansion of systemic oncological therapy). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14344por Li, Yanpeng, Cao, Le, Ye, Mei, Xu, Rong, Chen, Xin, Ma, Yingying, Tian, Ren-Rong, Liu, Feng-Liang, Zhang, Peng, Kuang, Yi-Qun, Zheng, Yong-Tang, Zhang, Chiyu“…Intravenous drug users (IDUs) are a high-risk group for HIV-1, hepatitis C virus (HCV), and hepatitis B virus (HBV) infections, which are the leading causes of death in IDUs. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14345por Bi, Jing-Hao, Yuan, Hui-Yun, Jiang, Yu, Zhang, Yun, Zheng, Wen-Wei, Zhang, Lei, Li, Zhuo-Ying, Li, Hong-Lan, Tan, Yu-Ting, Zhao, Wen-Sui, Xiang, Yong-Bing“…To reduce the burden of digestive tract cancers, the government and researchers should develop and promote a healthy diet, organize a screening, and reduce the prevalence of smoking, alcohol drinking, and hepatitis B virus and hepatitis C virus infections. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s44197-022-00047-3.…”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14346por Kang, Woo-Hyoung, Hwang, Shin, Kim, Jong Man, Lee, Kwang-Woong, Joo, Dong Jin, You, Young Kyoung, Ryu, Je Ho, Kim, Bong-Wan, Choi, Donglak, Kim, Dong-Sik, Nah, Yang Won“…In patients with hepatitis B virus infection, they were 6.0 ng/mL and 26 mAU/mL in the HCC group and 3.2 ng/mL and 21 mAU/mL in the no-HCC group, respectively (P<0.001 and P<0.001). In patients with hepatitis C virus infection, they were 10.7 ng/mL and 37 mAU/mL in the HCC group and 2.6 ng/mL and 21 mAU/mL in the no-HCC group, respectively (P<0.001 and P=0.117). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14347por Wang, Pinggui, Zhang, Lijie, He, Jian, Zhang, Guomin, Ma, Yvan, Lv, Weimin, Zhang, Xiaoshu, An, Jin“…Among reported cases, 81% had been tested for Alanine aminotransferase, 52% for hepatitis C antibody, 80% with liver ultrasound, 32% for hepatitis A antibody, and 7% for hepatitis B virus (HBV) DNA. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14348por Kay, Emma Sophia, Creasy, Stephanie, Batey, D Scott, Coulter, Robert, Egan, James E, Fisk, Stuart, Friedman, Mackey Reuel, Kinsky, Suzanne, Krier, Sarah, Noble, Victor, Turan, Bulent, Turan, Janet M, Yu, Lan, Hawk, Mary“…Aim 2 will explore the interplay between patient-perceived harm reduction, intersectional stigma and clinical outcomes related to HIV, hepatitis C (if applicable) and substance use-related outcomes through surveys (n=500) and focus groups (k=6, total n=36) with PWH who use drugs. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14349por Tsai, Hung-Chin, Chen, I-Tzu, Chang, Hui-Min, Lee, Susan Shin-Jung, Chen, Yao-Shen“…The resistance rates to nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase strand transfer inhibitors (INSTIs) were 3.3%, 6.9%, 0% and 1.8%, respectively. The patients with hepatitis C infection were more likely to have pol resistance (aHR 5.767, CI 1.232–26.991, p=0.026). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14350por Hallur, Vinaykumar, Gahlot, Pritika, Sirka, Chandra Sekar, Sahu, Supriya, Tudu, Malati“…Serological tests did not reveal the presence of HIV, Hepatitis B, or Hepatitis C infection. A clinical diagnosis of black grain mycetoma was made and the patient was sent to mycology laboratory for fungal culture. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14351por Mohamed, Essa A, Giama, Nasra H, Abdalla, Abubaker O, Shaleh, Hassan M, Oseini, Abdul M, Ali, Hamdi A, Ahmed, Fowsiyo, Taha, Wesam, Ahmed Mohammed, Hager, Cvinar, Jessica, Waaeys, Ibrahim A, Ali, Hawa, Allotey, Loretta K, Ali, Abdiwahab O, Mohamed, Safra A, Harmsen, William S, Ahmmad, Eimad M, Bajwa, Numra A, Afgarshe, Mohamud D, Shire, Abdirashid M, Balls-Berry, Joyce E, Roberts, Lewis R“…BACKGROUND: Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are known risk factors for liver disease, cirrhosis and hepatocellular carcinoma (HCC). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14352por Moussavou-Boundzanga, Pamela, Itoudi Bignoumba, Patrice Emery , Mouinga-Ondeme, Augustin, Iroungou, Berthe Amelie, Bivigou-Mboumba, Berthold, Marchio, Agnès, Saibou, Maryam, Moussavou Kombila, Jean-Baptiste , Pineau, Pascal“…A frequently dysmetabolic condition synergizing with hepatitis C (anti-HCV, 73.8% vs 22.7%, p < 0.0001) in females and a male cancer promoted by recreational toxicants and chronic hepatitis B (HBsAg, 83.5% vs 35.9%, p < 0.0001) were observed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14353por Kushner, Tatyana, Park, Claire, Masand, Dana, Rosenbluth, Emma, Carroll, Carin, Grace, Marie, Rodriguez-Rivas, Clara, De La Cruz, Hernis, Overbey, Jessica, Sperling, Rhoda“…Of these patients, 131 of 996 (13.2%) had elevated ALT ≥25 IU/L; 20 (2%) had ALT ≥50, 6 (0.6%) had ALT ≥125 and 3 (0.3%) had ALT ≥250. 61/131 (46.6%) of patients with ALT ≥25 IU/L had not had LTs checked during routine pregnancy care. 20 (15%) of individuals with abnormal LT had preeclampsia; 5 (4%) had cholestasis of pregnancy; 1 (0.8%) had hepatitis C; there were no other chronic liver diseases diagnosed. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14354por Fanciulli, Chiara, Berenguer, Juan, Busca, Carmen, Vivancos, María J., Téllez, María J., Domínguez, Lourdes, Domingo, Pere, Navarro, Jordi, Santos, Jesús, Iribarren, José A., Morano, Luis, Artero, Arturo, Moreno, Javier, Rivero‐Román, Antonio, Santos, Ignacio, Giner, Livia, Armiñanzas, Carlos, Montero, Marta, Manzardo, Christian, Cifuentes, Carmen, García, Coral, Galindo, María J., Ferrero, Oscar L., Sanz, José, de la Fuente, Belén, Rodríguez, Carmen, Gaspar, Gabriel, Pérez, Laura, Losa, Juan E., Force, Luis, Veloso, Sergio, Martínez‐Alfaro, Elisa, Jarrín, Inmaculada, De Miguel, Marta, González Garcia, Juan“…OBJECTIVES: We assessed the prevalence of anti‐hepatitis C virus (HCV) antibodies and active HCV infection (HCV‐RNA‐positive) in people living with HIV (PLWH) in Spain in 2019 and compared the results with those of four similar studies performed during 2015–2018. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14355por Laursen, Tea Lund, Bossen, Lars, Pihl, Rasmus, Troldborg, Anne, Sandahl, Thomas Damgaard, Hansen, Annette Gudmann, Folserass, Trine, Vesterhus, Mette, Grønbæk, Henning, Thiel, Steffen“…METHODS: We developed an immunoassay specific for ITIH4 and determined ITIH4 plasma concentrations in 66 PBC, 126 PSC, 92 autoimmune hepatitis (AIH), 67 chronic hepatitis C (CHC), 33 alcoholic hepatitis (AH) patients and 138 healthy controls (HCs). …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14356“…Alphavirus 6K, human immunodeficiency virus type 1 Vpu (HIV-Vpu), influenza A virus M2 (IAV-M2), and hepatitis C virus P7 (HCV-P7) are transmembrane ion channel proteins that play essential roles in virus assembly, budding, and entry. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14357por Bradley, Heather, Austin, Chelsea, Allen, Sean T., Asher, Alice, Bartholomew, Tyler S., Board, Amy, Borquez, Annick, Buchacz, Kate, Carter, Anastasia, Cooper, Hannah L.F., Feinberg, Judith, Furukawa, Nathan, Genberg, Becky, Gorbach, Pamina M., Hagan, Holly, Huriaux, Emalie, Hurley, Hermione, Luisi, Nicole, Martin, Natasha K., Rosenberg, Eli S., Strathdee, Steffanie A., Jarlais, Don C. Des“…PWID experienced both interruptions and changes to drug supply and delivery modes of harm reduction, treatment, and other medical services, leading to potentially increased risks for HIV, hepatitis C virus (HCV), and overdose. Given surveillance and research disruptions, proximal, indirect indicators of infectious diseases and overdose should be developed for timely measurement of health effects of the pandemic on PWID. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14358por Hu, Haiyang, Chen, Yuheng, Shi, Lingen, Liu, Xiaoxia, Xu, Zhuping, Sun, Lin, Zhao, Xiuping, Zhou, Ying, Lu, Jing, Zhang, Zhi, Liu, Xiaoyan, Fu, Gengfeng“…Venous blood specimens were collected for HIV, hepatitis C (HCV), and syphilis testing using serological testing methods. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14359“…KEY MESSAGES: • High burden of active Hepatitis C infection and low Hepatitis B vaccination coverage among people who inject drugs in Berlin and Bavaria require improved access to treatment and prevention efforts. • National Monitoring is needed to inform and support the viral hepatitis/HIV/STI elimination process among people who inject drugs in Germany.…”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
14360por Chen, Shuyi, Wu, Jiqin, Yang, Xiaofeng, Sun, Qiuli, Liu, Su, Rashid, Farooq, Dzakah, Emmanuel Enoch, Wang, Haiying, Wang, Jufang, Gong, Peng, Tang, Shixing“…The virus-encoded RNA-dependent RNA polymerase (RdRp) is responsible for viral replication, and its fidelity is closely related to viral diversity, pathogenesis, virulence, and fitness. Hepatitis C virus (HCV) and the second human pegivirus (HPgV-2) belong to the family Flaviviridae and share some features, including similar viral genome structure. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto